GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Unsecured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Unsecured Loans | ₹513 Cr | - | ₹3,852 Cr | ₹2,572 Cr | ₹3,889 Cr |
What is the latest Unsecured Loans ratio of GLENMARK PHARMACEUTICALS ?
| Year | Unsecured Loans |
|---|---|
| Mar2025 | ₹513 Cr |
| Mar2024 | - |
| Mar2023 | ₹3,852 Cr |
| Mar2022 | ₹2,572 Cr |
| Mar2021 | ₹3,889 Cr |
How is Unsecured Loans of GLENMARK PHARMACEUTICALS Trending?
| Years | Unsecured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹513 Cr | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹3,852 Cr | 49.79 | |
| Mar2022 | ₹2,572 Cr | -33.87 | |
| Mar2021 | ₹3,889 Cr | - | |
Compare Unsecured Loans of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹61,480.1 Cr | -0.3% | -1.4% | 4.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹220,946.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,907.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹118,674.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,648.7 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.3% |
-1.4% |
4.2% |
| SENSEX | 2.4% |
1.5% |
-4.3% |
You may also like the below Video Courses